Man Group’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-43,000
Closed -$246K 2104
2022
Q1
$246K Buy
+43,000
New +$246K ﹤0.01% 1790
2020
Q3
Sell
-315,161
Closed -$4.64M 1813
2020
Q2
$4.64M Buy
+315,161
New +$4.64M 0.02% 709
2020
Q1
Sell
-163,328
Closed -$3.84M 1687
2019
Q4
$3.84M Buy
+163,328
New +$3.84M 0.01% 1091
2019
Q3
Sell
-29,036
Closed -$540K 1829
2019
Q2
$540K Sell
29,036
-15,004
-34% -$279K ﹤0.01% 1651
2019
Q1
$1.08M Sell
44,040
-16,742
-28% -$409K ﹤0.01% 1549
2018
Q4
$1.58M Buy
+60,782
New +$1.58M 0.01% 1291
2018
Q3
Sell
-18,432
Closed -$716K 2129
2018
Q2
$716K Buy
+18,432
New +$716K ﹤0.01% 1691